Home/Enara Bio/Joseph Dukes
JD

Joseph Dukes

CSO

Enara Bio

Therapeutic Areas

Enara Bio Pipeline

DrugIndicationPhase
ENA101 (targeting DARKFOX)Solid TumorsPre-clinical